• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Good functional vision in presbyopic patients is attainable


Since our practice began offering presbyopia-correcting IOLs, we have implanted 450 of them. One in five of our cataract and refractive lens exchange patients chooses one of these new lenses. The AcrySof ReSTOR lens (Alcon Laboratories) accounts for 80% of our presbyopia-correcting implants, while the ReZoom (Advanced Medical Optics) and the crystalens (eyeonics) together represent 20%.

Determining visual needs

Offering presbyopia-correcting IOLs requires that physicians pay very close attention to patients' visual needs, i.e., what they want their surgery to allow them to do. First, patients fill out a questionnaire on which they list the activities they need or want to do most. The majority of our patients report that being able to see at near and distance is most important to them. They also indicate that if they can have good vision at those two distances, they could tolerate occasionally having to wear glasses for other activities. In this scenario, the ReSTOR lens is their best option.

Mix/match strategy

We take a careful approach to mixing and matching lenses for several reasons. Mainly, we believe the apodized diffractive optic design of the ReSTOR lens gives patients the best chance of good functional vision without correction at near, intermediate, and distance-especially when they have bilateral implants. Given what we know about binocular summation (that bilateral vision is better than vision with one eye), I am not convinced that using two very different types of lenses in one patient is the best way to maximize the visual system.

Our results confirm this. Patients who have received the ReSTOR lenses have excellent near and distance vision, and their intermediate vision is better than I had anticipated. By tracking satisfaction among patients who received bilateral ReSTOR lenses and remain in our care after surgery, we have learned that 90% never wear glasses; 100% have better than 20/40 uncorrected distance vision; and 90% see J3 or better at near. In addition, patients who use computers do better with ReSTOR lenses than has been reported. Furthermore, patients are generally satisfied with their first ReSTOR implant, but are happiest once they receive their second one. We do find these patients may need a little more light for their intermediate distance viewing, but generally they function very well under normal lighting conditions.

Prior to initiating the trial waiting period before implanting a different lens in the second eye, we had used the mix-and-match strategy in six patients. One of those patients is unhappy with the results. Because she uses the computer frequently and also reads a lot, we implanted a ReSTOR lens in her non-dominant eye and a ReZoom lens in her dominant eye. She has requested that we remove the ReZoom lens, and we have advised her to take more time to try to adjust before we proceed.

Related Videos
EyeCon Co-chair Oluwatosin U. Smith, MD: Passion for Research and Education Drives Her Commitment to Ophthalmology
Dr. SriniVas Sadda Discusses Vision for ARVO as New President: Collaboration, Funding Challenges, and Impact of Annual Meetings
Highlights from the 18th Annual Controversies in Modern Eye Care Symposium: Arjan Hura, MD, on Refractive Surgery, Retina Care, and Record Attendance
ASCRS 2024: ViaLase Updates on Nonincisional Glaucoma Treatment Targeting Trabecular Meshwork
Dr. Neda Nikpoor Shares Practical Techniques to Combat Unconscious Gender Bias and Promote Gender Equality in Ophthalmology
ASCRS 2024: George O. Waring, MD, shares early clinical performance of bilateral Odyssey implantation
ASCRS 2024: Deborah Gess Ristvedt, DO, discusses third-generation trabecular micro-bypass
Arjan Hura, MD, highlights the clinical and surgical updates at CIME 2024
Neda Nikpoor, MD, talks about the Light Adjustable Lens at ASCRS 2024
Elizabeth Yeu, MD, highlights from a corneal case report for a patient undergoing the triple procedure
© 2024 MJH Life Sciences

All rights reserved.